CRISPR Therapeutics AG
NASDAQ:CRSP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
CH |
|
A
|
American Electric Power Company Inc
XHAM:AEP
|
US |
|
CTBC Financial Holding Co Ltd
TWSE:2891
|
TW |
|
Bunge Ltd
NYSE:BG
|
US |
|
P
|
Perfect Corp
NYSE:PERF
|
TW |
|
Reliance Industries Ltd
F:RLI
|
IN |
|
Lynas Rare Earths Ltd
ASX:LYC
|
MY |
|
Northwest Pipe Co
NASDAQ:NWPX
|
US |
|
T
|
Teads BV
NASDAQ:TEAD
|
NL |
|
Tesla Inc
NASDAQ:TSLA
|
US |
|
A
|
Anglo American Platinum Ltd
JSE:AMS
|
ZA |
|
Multi Bintang Indonesia Tbk PT
IDX:MLBI
|
ID |
|
Smith Micro Software Inc
NASDAQ:SMSI
|
US |
|
W
|
Walmart Inc
XHAM:WMT
|
US |
|
A
|
ACI Worldwide Inc
XBER:TSA
|
US |
|
United Overseas Bank Ltd
SGX:U11
|
SG |
|
Orient Cement Ltd
NSE:ORIENTCEM
|
IN |
|
Banca Popolare Di Sondrio SpA
MIL:BPSO
|
IT |
|
Servcorp Ltd
ASX:SRV
|
AU |
|
Prosus NV
OTC:PROSF
|
NL |
|
Aptargroup Inc
NYSE:ATR
|
US |
|
U
|
U-Haul Holding Co
NYSE:UHAL.B
|
US |
Wall St Price Targets
CRSP Price Targets Summary
CRISPR Therapeutics AG
According to Wall Street analysts, the average 1-year price target for
CRSP is 81.92 USD with a low forecast of 33.33 USD and a high forecast of 305.55 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CRSP's stock price target?
Price Target
81.92
USD
According to Wall Street analysts, the average 1-year price target for
CRSP is 81.92 USD with a low forecast of 33.33 USD and a high forecast of 305.55 USD.
What is the Revenue forecast for CRISPR Therapeutics AG?
Projected CAGR
119%
Over the last 10 years, the compound annual growth rate for Revenue has been 33%. The projected CAGR for the next 8 years is 119%.